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Abstract
Background: The autosomal recessive ataxias are a heterogeneous group of disorders that are characterized by complex neurological features in addition to
progressive ataxia. Hyperkinetic movement disorders occur in a significant proportion of patients, and may sometimes be the presenting motor symptom.
Presentations with involuntary movements rather than ataxia are diagnostically challenging, and are likely under-recognized.
Methods: A PubMed literature search was performed in October 2015 utilizing pairwise combinations of disease-related terms (autosomal recessive ataxia, ataxia–
telangiectasia, ataxia with oculomotor apraxia type 1 (AOA1), ataxia with oculomotor apraxia type 2 (AOA2), Friedreich ataxia, ataxia with vitamin E deficiency),
and symptom-related terms (movement disorder, dystonia, chorea, choreoathetosis, myoclonus).
Results: Involuntary movements occur in the majority of patients with ataxia–telangiectasia and AOA1, and less frequently in patients with AOA2, Friedreich
ataxia, and ataxia with vitamin E deficiency. Clinical presentations with an isolated hyperkinetic movement disorder in the absence of ataxia include dystonia or
dystonia with myoclonus with predominant upper limb and cervical involvement (ataxia–telangiectasia, ataxia with vitamin E deficiency), and generalized chorea
(ataxia with oculomotor apraxia type 1, ataxia-telangiectasia).
Discussion: An awareness of atypical presentations facilitates early and accurate diagnosis in these challenging cases. Recognition of involuntary movements is
important not only for diagnosis, but also because of the potential for effective targeted symptomatic treatment.
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Introduction
The autosomal recessive cerebellar ataxias are a large and
heterogeneous group of conditions that often present during child-
hood or adolescence. Many of these conditions are characterized by
complex, mixed neurological syndromes that include sensorimotor
peripheral neuropathy, spasticity, or loss of proprioception and
vibration sense due to dorsal column degeneration, in addition to
ataxia. Furthermore, ataxia may not be the sole movement
abnormality. Hyperkinetic movement disorders, including dystonia,
chorea, myoclonus, and tremor, occurred in about one-third of
patients with progressive autosomal recessive ataxia in one cohort.1
The severity of the accompanying involuntary movements may vary
from mild to severe. In some instances, the involuntary movements,
rather than ataxia, may be the initial neurological symptom, making
accurate and timely diagnosis particularly challenging.
The clinical and genetic characteristics of the autosomal recessive
ataxias have been well described in several recent reviews2,3 and are
summarized in Table 1. The spectrum of involuntary movements in the
autosomal dominant spinocerebellar ataxias has also been described
previously.4 The focus of this review is to describe the spectrum and,
where possible, the frequency of involuntary movements associated with
selected childhood-onset autosomal recessive ataxia syndromes in which
involuntary movements are very common, or are under-recognized as a
presenting feature of the disease: ataxia–telangiectasia (A-T), ataxia with
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oculomotor apraxia types 1 and 2 (AOA1 and AOA2), Friedreich ataxia
(FA), and ataxia with vitamin E deficiency (AVED). For each condition,
presentations in which the hyperkinetic movement disorder is prominent
are highlighted.
Methods
A literature search of the PubMed database was performed in October
2015, utilizing pairwise combinations of disease-related terms (autosomal
recessive ataxia, A-T, ataxia with oculomotor apraxia type 1, AOA1,
ataxia with oculomotor apraxia type 2, AOA2, Friedreich ataxia, ataxia
with vitamin E deficiency) and symptom-related terms (movement
disorder, dystonia, chorea, choreoathetosis, myoclonus). Case reports and
case series published in peer-reviewed journals were included. The search
was limited to English language publications, with the exception of one
historical report on A-T in French.
Ataxia–telangiectasia
A-T is a multisystem disorder characterized by neurodegeneration,
immunodeficiency and a predisposition to malignancy. It is caused by
inactivating mutations in ATM, which encodes a serine-threonine
kinase that plays a critical role in DNA repair.5 The classical
phenotype is characterized by onset of axial and gait ataxia between
1 and 4 years of age after a period of normal motor development in
early infancy. Affected children proceed to develop progressive ataxia,
dysarthria, and oculomotor apraxia (an eye movement disorder
characterized by impaired voluntary initiation of horizontal saccades).
Oculocutaneous telangiectasias (small dilated blood vessels) usually
appear several years after neurological symptom onset.
The term ‘‘variant A-T’’ is sometimes used to describe patients
who have older age of onset, slower disease progression, and/or an
incomplete phenotype. These milder phenotypes are typically
associated with missense or splice site mutations that produce ATM
protein with some residual kinase activity. In contrast, patients with the
classic early-onset ataxia phenotype typically have truncating muta-
tions that result in absent or non-functional ATM protein.6,7 In
patients with milder disease, involuntary movements are often more
prominent than ataxia.7
A-T is commonly associated with a mixed hyperkinetic
movement disorder
Movement disorders, including dystonia, chorea, myoclonus, and
parkinsonism are established clinical features of A-T, and were
summarized in a recent review.8 Specifically, the longstanding
recognition of a mixed hyperkinetic movement disorder in a majority
of patients is illustrated by Sedgwick and Boder’s9 description, in 1960
of ‘‘variable choreoathetoid movements and posturing, [and] occa-
sional myoclonic jerks’’ in 15 of 20 patients. Approximately 90% of
adult and pediatric patients were observed to have involuntary
movements in several subsequent large case series, with some variation
in the precise characterization of the movements: choreoathetosis,10 or
a variable combination of dystonia, chorea, and myoclonus.7,11
Involuntary movements in A-T are variable and tend to be
progressive. In children with classic, early-onset disease, the movements
may remain mild compared with ataxia,9 but in patients with milder
disease, progressive involuntary movements can be the dominant motor
feature.7 Indeed, in what is now acknowledged to be the earliest
published report of A-T, Syllaba and Henner12 in 1926 described three
siblings with childhood-onset, slowly progressive athetosis of the face and
limbs who remained ambulatory throughout their teens.
There is some suggestion that chorea is more common than dystonia
in childhood (60% vs. 15% in one series of 57 children aged 2–19
years13), while dystonia becomes more apparent with advancing age.
One recent study of 14 adults with childhood-onset A-T reported
dystonia in 86%, myoclonus in 70%, but chorea in none.14
Myoclonus is reported to occur in 60–95% of patients.7,13,14
Myoclonus may occur in body regions affected by dystonia,14–16 or in
distinct regions.14,17,18 The trunk, neck, and upper limbs are most
frequently affected, and jerks worsen with action. Characterization of
the movements with surface electromyography revealed a burst
duration of 30–80 ms in one case,18 and longer duration bursts of
.50 ms in others.14 These findings suggest myoclonus of subcortical
origin. In rare cases, myoclonus may become the predominant
motor finding, several years after initial onset of ataxia (Myoclonus in
A-T: http://dx.doi.org/10.1016/j.braindev.2014.06.001; http://
dx.doi.org/10.7916/D88P5Z9X).15,17,18 There are anecdotal reports
of symptomatic improvement of myoclonus following treatment with
either levetiracetam17 or clonazepam.18
Overall, the data suggest that dystonia in A-T is frequently
accompanied by jerky movements due to chorea, myoclonus, or both.
These clinical observations are supported by a recent kinematic analysis
of upper limb movements in patients with A-T, in which both slow and
rapid non-rhythmic adventitious movements were recorded using an
accelerometer attached to the hand during rest, posture-holding, and
finger-to-nose reaching movements.19 The same study additionally
documented rhythmic oscillatory movements, consistent with upper
limb postural and action tremor, in the vast majority of patients (79/80).
Involuntary movements as the presenting symptom in A-T
The presence of subtle dystonia or chorea may provide an early clue
to the diagnosis in very young children with classic A-T when overt
signs of progressive ataxia are lacking.11,20 Initial motor symptoms are
often quite non-specific. Many infants have a history of walking on
time, but continue to appear clumsy or unsteady through the second
year of life, prompting neurological evaluation. On examination, the
gait is usually narrow-based, but patients veer off course, and dystonic
posturing of the upper or lower limbs is often observed.20 Chorea may
appear as mild fidgety movements of the hands and feet at this age.20
A small number of patients with prominent, jerky chorea involving the
face or the whole body in early childhood as the dominant presenting
feature have been reported.21,22 Confirmation of the diagnosis of A-T
at this early stage can have important implications for genetic
counseling and family planning, and also permits recognition of the
potential risk of adverse consequences from future cancer treatment.22
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A-T may present with isolated dystonia (Table 2). Age of onset
as young as 2 years has been documented,23 although in most
reported cases, dystonia onset occurred later in childhood. The neck
and upper limbs were the most frequent initial sites of dystonia.14,24–28
In two patients, dystonia was later accompanied by myoclonus of the
head, trunk, or upper limbs, mimicking myoclonus–dystonia
(Dystonia and dystonia with myoclonus in A-T: http://dx.doi.org/
10.1016/j.parkreldis.2013.08.013; http://dx.doi.org/10.1212/WNL.
0b013e3182494d51).16,23,27 Some patients developed progressive
generalized dystonia.14,25,29 Dystonia improved markedly with levo-
dopa therapy in three siblings with adolescent-onset cervical
dystonia,26 but levodopa response was more modest15 or absent29–31
in other cases.
A specific homozygous founder missense mutation in the Canadian
Mennonite population (c.6200 C.A) is associated with a pure dystonia
or myoclonus–dystonia-like phenotype with predominant cervical and
upper limb involvement (Dystonia and dystonia with myoclonus in
A-T: http://dx.doi.org/10.1016/j.parkreldis.2013.08.013; http://
dx.doi.org/10.1212/WNL.0b013e3182494d51).16,23 In this popula-
tion, the 12 reported patients experienced onset of dystonia between
ages 1 and 20 years. Over half of the patients eventually developed
generalized dystonia, but none developed ataxia in adulthood.
Ataxia with oculomotor apraxia type 1
AOA1 is caused by mutations in APTX, which encodes aprataxin, a
nuclear protein involved in DNA strand-break repair32 (Table 1). Symptom
onset in AOA1 typically occurs in the first decade of life. The initial
manifestation in most patients is gait ataxia, followed by dysarthria and
upper limb dysmetria, and oculomotor apraxia. The ataxia is slowly
progressive, and all patients also develop an axonal sensorimotor
neuropathy that leads to eventual quadriparesis and loss of ambulation
approximately 7–10 years after disease onset.32,33
Chorea and dystonia both occur commonly in AOA1 (Dystonia
and chorea in AOA1; http://dx.doi.org/10.1056/NEJMra1006610)2.
Chorea is present in up to 80% of patients at onset,34 and is usually
most severe early in the disease course.34,35 The movements can affect
the face, laryngo-pharynx, and limbs. Chorea often subsides as the
disease progresses, and may disappear entirely in some patients,
particularly those who later develop severe neuropathy-related
weakness. Chorea remains persistent and disabling in a minority of
patients.34
Dystonia is present in about 50% of patients,36 and may be apparent
soon after disease onset,34,36,37 or develop several years into the disease
course,38 Most patients have upper limb dystonia that is less prominent
than either the ataxia or neuropathy. However, two Japanese patients
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Abbreviations: AOA, Ataxia with Oculomotor Apraxia; AVED, Ataxia with Vitamin E Deficiency.
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with progressive generalized dystonia as the dominant feature have
been described.37,38 In one of those two patients, dystonia improved
with clonazepam treatment (4 mg/day), but was not responsive to
either levodopa-carbidopa (250–25 mg/day) or trihexyphenidyl
(15 mg/day).37
Involuntary movements at presentation
Chorea was the most prominent presenting neurological feature in
six of the 14 patients in one series, leading to initial investigation in five
patients for Sydenham chorea, Huntington disease, or benign
hereditary chorea (Table 2).34
Ataxia with oculomotor apraxia type 2
AOA2 is caused by mutations in SETX, which encodes the protein
senataxin. Senataxin has a RNA-interacting helicase domain and a protein-
interacting amino-terminal domain, and plays important roles in RNA
processing and the maintenance of genomic stability.39 The AOA2 clinical
syndrome is characterized by slowly progressive ataxia, oculomotor apraxia,
and axonal sensorimotor peripheral neuropathy (Table 1). Symptom onset
occurs later than in AOA1, commonly during the second decade of life.
Gait ataxia is the most common initial symptom.40–42
Hyperkinetic movement disorders are less prevalent in AOA2 than
in AOA1, but they do occur. In the 90-patient series of Anheim
et al.,43 dystonia was detected in 14%, head tremor in 14%, and
chorea in 10% of patients. A slightly higher prevalence of 20–25% for
dystonia and chorea40 and for head tremor42 was reported in two
smaller series. Dystonia usually affects the hands,43 but trunk
involvement has also been reported.41 A few patients have a
combination of chorea and dystonia.40,41 Movements may either
remain stable40 or diminish over time.41,44 The relative stability of
movements in some cases may be attributable to the slower rate of
progression of weakness in AOA2 than in AOA1.
Dystonia in AOA2 has been reported to occur more frequently in
patients with milder disease. Milder phenotypes correlate with missense
mutations in the helicase domain of SETX (frequency of dystonia: 41.7%),
while more severe disease is associated with missense mutations outside
the helicase domain, truncating mutations, or deletions (frequency of
dystonia: ,10%).43
There is a single report of symptomatic treatment with bilateral pallidal
deep brain stimulation (DBS) in a 19-year-old patient with upper and lower
limb dystonia, bilateral rest and action tremor of the arms, and jerky arm
movements suggestive of myoclonus.45 The patient’s arm tremor and
myoclonus improved, although there was no change in the Unified
Dystonia Rating Scale (UDRS) score.
Involuntary movements at presentation
Rarely, involuntary movements have been reported as a prominent
presenting symptom of AOA2, although they are accompanied by
ataxia in almost all cases (Table 2). Two patients had upper limb
dystonia as an initial symptom.40,42 Two siblings presented with
prominent chorea of the trunk and face.44 One patient had isolated
head tremor as the initial symptom at age 9 years.42
Friedreich ataxia
FA is the most common autosomal recessive ataxia in Caucasian
populations. The neurological syndrome is characterized by progres-
sive ataxia, dysarthria, limb weakness, impaired proprioception and
vibration sense, areflexia, and extensor plantar responses (Table 1).
Homozygous GAA triplet repeat expansions in exon 1 of the frataxin
gene (FXN) are detected in over 90% of patients. The remaining
patients have an abnormal GAA expansion on one allele coupled with
another pathogenic variant on the other allele.
Involuntary movements are not uncommon in FA, but only rarely
are they the dominant feature. Of 29 patients with FA in one series,
17% had postural tremor of the upper limbs or head, and 45% had
mild upper limb dystonia.46 The dystonia was observed on examina-
tion, but was usually unnoticed by patients, overshadowed by their
other motor symptoms.
A handful of case reports describe prominent dystonia in patients
with FA who had initially presented with ataxia. One 20-year-old
patient had fixed rotational torticollis together with episodic exercise-
induced dystonic head tremor.47 Two patients in their late teens
experienced trunk spasms and writer’s cramp.48 Rare reports of chorea
as an early disease feature also exist (see below).49–51
Involuntary movements at presentation
An atypical presentation of generalized chorea without ataxia has
been described in three patients (Table 2). The first two had symptom
onset at ages 19 and 12 years and were both homozygous for the
typical intronic GAA expansion.49 The third, with compound
heterozygous mutations, experienced atypically early onset at age
4 years with progressive trunk and limb chorea prior to the onset of
ataxia at age 12.51 Simultaneous onset of apparently acute ataxia with
chorea of the tongue and hands has also been reported in one 10 year
old boy with compound heterozygous mutations.50
Ataxia with vitamin E deficiency
AVED is one of the few treatable neurodegenerative diseases,
making prompt diagnosis critical. Patients have low levels of plasma
vitamin E as a result of mutations in TTPA, the gene encoding the
a-tocopherol transfer protein, which normally incorporates
a-tocopherol into very low density lipoproteins in the liver for
secretion into the circulation.52 Treatment with high-dose vitamin E
supplementation prevents disease progression, and may partially
reverse symptoms in some cases.53,54
AVED is often characterized as a FA-like syndrome. The diseases
share the common features of progressive gait ataxia, dysarthria,
areflexia, and impaired proprioception and vibration sense (Table 1).
A distinguishing motor feature in AVED, not observed in patients with
FA, is a postural head tremor (i.e., tremor that is present when the
patient is upright), reported in 28%55 and 44%54 of patients in two
respective series (Table 2).
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Dystonia was observed in 13% of patients with AVED in the largest
published series to date.55 Additional case reports demonstrate that
dystonia may be a prominent finding.56–60 The face and neck were the
most commonly affected body regions, but in half of the 10 patients
reported to date, dystonia spread to become generalized.58,59,61
Dystonia usually emerged after patients had already developed
progressive cerebellar symptoms.
Involuntary movements at presentation
Importantly, dystonia as the presenting symptom of AVED has been
described in three patients in two separate reports.57,62 In all three
cases, the dystonia was cervical and associated with irregular head
tremor (Dystonia in AVED; http://dx.doi.org/10.7916/D8B85820)62.
In one patient, the combination of posturing and jerky head
movements mimicked myoclonus–dystonia (Table 2).57 The involun-
tary movements preceded the onset of ataxia by 3–6 years, suggesting
that we should screen for vitamin E deficiency not just in the context of
ataxia, but also in patients with progressive dystonia or dystonia with
myoclonus, particularly when the neck is involved.
The specific response of dystonia to treatment with vitamin E
appears to vary, and is not always specifically described. Dystonia
improved with treatment in at least two cases.54,57 However, dystonia
progressed despite treatment in a patient who developed dystonia
2 years after ataxia onset, while on high-dose vitamin E supplementa-
tion.59 The patient’s dystonia responded partially to symptomatic
treatment with botulinum toxin injections and trihexyphenidyl.
Data about the long-term response of other symptoms, including head
tremor and ataxia, to vitamin E therapy are limited. Head tremor tended
to improve,53 while improvements in gait ataxia were more limited in
two studies that describe treatment response.53,54 A few patients
experienced progressive ataxia despite vitamin E therapy.54 Most
patients seem to experience stabilization rather than a significant reversal
of symptoms,54 highlighting the importance of prompt diagnosis.
Pathophysiology of involuntary movements in ataxia
syndromes
The pathophysiological basis of the involuntary movements
observed in the diseases described above remains unknown.
Involuntary movements have traditionally been associated with
dysfunction of the basal ganglia. Does the presence of involuntary
movements therefore imply basal ganglia involvement in these ataxia
syndromes? An alternative hypothesis is that cerebellar pathology may
be implicated in some way in the pathogenesis of involuntary
movements such as dystonia and chorea.
The main common pathological finding in brain in A-T, AOA1,
AOA2, and AVED is a marked loss of cerebellar Purkinje cells.63,65
In FA, Purkinje cell loss is relatively mild, and ataxia is attributed to
severe atrophy of the dentate nucleus,66 in combination with
proprioceptive sensory loss from dorsal column degeneration.
What evidence is there for basal ganglia dysfunction or pathology?
Data from one fludeoxyglucose positron emission tomography study of
adult patients with A-T demonstrated hyperactivity in the globus
pallidus that correlated inversely with subjects’ motor performance.67
However, evidence of basal ganglia pathology on post-mortem
examination in A-T (the most extensively characterized of the
disorders, with published neuropathological reports from over 30
patients) is scarce.64,65,68,69 The possibility of abnormal basal ganglia
neuronal function without detectable cell loss remains possible.
There has been recent interest in a possible role of the cerebellum in
the pathogenesis of involuntary movements via the interaction of
cerebellar and basal ganglia circuits. In the past decade, results from
anatomical experiments have provided evidence for disynaptic path-
ways connecting the dentate nucleus and striatum,70 and the
subthalamic nucleus and cerebellar cortex.71 A potential role of the
cerebellum in the pathogenesis of dystonia has been a particular topic
of study and debate,72 (reviewed by Prudente et al.73).
Conclusions
Involuntary movements occur in the majority of patients with A-T
and AOA1, and less frequently in patients with AOA2, FA, and
AVED. Occasionally, the hyperkinetic movement disorder, rather
than ataxia, may be the most prominent initial motor finding.
Presentations with isolated dystonia, dystonia with myoclonus, and
generalized chorea do occur. In a child or adolescent with progressive
dystonia, particularly in a craniocervical or upper limb distribution,
A-T and AVED should be considered in the differential diagnosis.
Recognition of hyperkinetic movement disorders in these diseases
has important implications for diagnosis, genetic counseling, and
treatment. In the appropriate clinical context, screening laboratory
investigations may rapidly guide further diagnostic testing (Table 1).
When movement symptoms are severe and functionally disabling,
accurate characterization is also important for treatment. In contrast
to the functional deficits resulting from cerebellar degeneration and
motor neuropathy, involuntary movements are often amenable to
symptomatic treatment.
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